Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Windtree Therapeutics Inc /De/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
Windtree Therapeutics Inc /De/ Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$240K.
Windtree Therapeutics Inc /De/ Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $71K.
Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2023 was $0.000.
Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2022 was -$1.37M, a 86.3% increase from 2021.
Windtree Therapeutics Inc /De/ annual Income Tax Expense (Benefit) for 2021 was -$9.99M.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$0	+$1.37M		Jan 1, 2023	Dec 31, 2023	10-K	2024-04-16
2022	-$1.37M	+$8.62M	+86.3%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-16
2021	-$9.99M	-$9.99M		Jan 1, 2021	Dec 31, 2021	10-K	2023-03-31
2020	$0			Jan 1, 2020	Dec 31, 2020	10-K	2022-03-31
2015	$0	$0		Jan 1, 2015	Dec 31, 2015	10-K/A	2016-03-29
2014	$0	$0		Jan 1, 2014	Dec 31, 2014	10-K/A	2016-03-29
2013	$0	$0		Jan 1, 2013	Dec 31, 2013	10-K	2015-03-16
2012	$0			Jan 1, 2012	Dec 31, 2012	10-K	2015-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.